PerkinElmer Optoelectronics

Manufacturer of Specialty Lighting and Medical Measurement Equipment

Manufacturer

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. Combining operational excellence and technology expertise with an intimate understanding of its customers' needs, PerkinElmer provides products and services for a range of applications that require innovation, precision and reliability.

Business Units

We design, manufacture, market and service products and systems within two business units:

Life and Analytical Sciences - A leading provider of precision instrumentation, reagents and chemistries, software and services for a wide range of scientific and industrial laboratory applications, including genetic screening, drug discovery and development, environmental monitoring, food and beverage quality, and chemical analysis.

Optoelectronics - Providing a broad range of digital imaging, sensor and specialty lighting components used in biomedical, consumer products and other specialty end markets.

PerkinElmer Optoelectronics Postings

50 news releases »

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

Feb 06, 2009 | WALTHAM, Mass., Feb 03, 2009 (BUSINESS WIRE) PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, announced the acquisition of Opto Technology, Inc., a leading supplier of light-emitting diode (LED) based lighting components and subsystems.

PerkinElmer Announces Financial Results for the Fourth Quarter of 2008

Jan 30, 2009 | PerkinElmer, Inc. (NYSE: PKI - News), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the fourth quarter ended December 28, 2008. The Company reported GAAP earnings per share from continuing operations of $0.29. On a non-GAAP basis, which includes the adjustments noted in the attached reconciliation, the Company announced adjusted earnings per share of $0.48, which is within the range of the Company's prior guidance.

PerkinElmer Launches Volocity 5� High Performance Imaging Acquisition and Analysis Software

Nov 18, 2008 | Washington, D.C. - PerkinElmer, Inc., a global leader in life science research, drug discovery and cellular science, today announced the launch of the Volocity� 5 high performance imaging software suite, developed by Improvision, a PerkinElmer company, at the Society for Neuroscience conference.

PerkinElmer Launches Online Radiochemical Tool Kit To Support Customers' Critical Laboratory Requirements

Sep 16, 2008 | WALTHAM � PerkinElmer, a global leader in life science research, drug discovery and cellular science, today announced the launch of its online radiochemical tool kit, a comprehensive suite of interactive, Web-based applications designed to provide researchers with hands-on access to information they need to support their critical lab requirements. The new online radiochemical tool kit helps customers perform key lab calculations, assists with lab equipment and reagent management, and provides new and more efficient methods for locating key product and technical information.

PerkinElmer to Present at UBS Global Life Sciences Conference

Sep 16, 2008 | WALTHAM, Mass.(BUSINESS WIRE)Sept. 16, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008, at 12:30 p.m. Eastern Time at the Grand Hyatt Hotel in New York City.

PerkinElmer to Triple Neonatal Screening Capacity in Mexico

Jul 24, 2008 | WALTHAM, Mass.(BUSINESS WIRE)July 21, 2008PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced a one-year agreement with the Mexican Ministry of Health, la Secretaria de Salud, to expand its newborn screening program across Mexico. Under the terms of the agreement, PerkinElmer will provide instrumentation, reagents and screening expertise that will help the Ministry of Health screen for congenital hypothyroidism and triple its screening capacity. The expanded program began in May 2008.

Dr. Alan Fletcher Joins PerkinElmer as Vice President of Bio-Discovery Business Development

Jul 14, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 14, 2008--PerkinElmer, Inc. (NYSE: PKI), a leader in Health Sciences and Photonics, today announced that Alan Fletcher, Ph.D., has joined the Company as vice president, business development for PerkinElmer's Life and Analytical Sciences business. In this role, Fletcher will be responsible for growing the Bio-discovery business through the development of strategic partnerships and alliances in the life science research area, and the introduction of new technologies for GPCR, kinase and biomarker drug target classes.

PerkinElmer Appoints Its Chief Scientific Officer Daniel Marshak to Lead Greater China Operations

Jul 08, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--July 7, 2008--PerkinElmer, Inc. (NYSE: PKI), today announced the appointment of Daniel R. Marshak, Ph.D., to the additional position of president of its Greater China operations. In this role, Marshak will assume overall leadership of PerkinElmer in Greater China, and will be responsible for expanding its resources in the region to drive innovation and new product introductions. He will be based out of Shanghai, strengthening the Company's executive and scientific presence in the country. Marshak will continue in his role as senior vice president and chief scientific officer for the Company.

PerkinElmer Unveils Tailored LIMS Solutions for Water, Food and Petrochemical Laboratory Customers

Jul 01, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 30, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced three market-specific LABWORKS(TM) Laboratory Information Management Systems (LIMS) packages that address increasing regulatory and compliance pressures. The new packages are aimed at addressing the critical data management needs of customers in water, food and petrochemical laboratories.

PerkinElmer Receives 2008 Life Science Industry Award for Achievement in High Throughput Screening

Jun 16, 2008 | WALTHAM, Mass.--(BUSINESS WIRE)--June 12, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced that it has received top honors in the Life Science Industry Awards for High Throughput Screening (HTS) and Analysis Systems. For the second consecutive year, the Company was named a winner in the Life Science Industry Awards, which are determined based on the input of nearly 4,500 scientists worldwide, and recognize life science companies offering best-in-class technology and service over the past year.

40 more news releases from PerkinElmer Optoelectronics »

ONLINE IPC Training & Certification
MSD Dry Cabinets
Reflow Oven

Voidless Reflow Soldering